Strados Labs Forms Collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study
Starting in early 2023 the biopharmaceutical company will use the Strados RESP™ Biosensor to remotely monitor cough and crackles in patients at home. Philadelphia, PA January 26, 2023 – Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely...
Strados Labs Named a Winner of 2022 Best of Sensors Awards
Recognized in the Wearable Category for the first-of-its-kind smart sensor platform for respiratory health, RESP® Philadelphia, PA, July 14, 2022 – Today, Strados Labs announces it has been named a winner in the Wearables category of the 2022 Best of Sensors Awards...
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®
Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received...
Recent Comments